½ÃÀ庸°í¼­
»óǰÄÚµå
1360306

µðÁöÅÐ Çコ ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2023-2031³â)

Digital Health Market (Product: Healthcare Information Systems and Wearable Devices; and Component: Software, Hardware, and Services) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Transparency Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 250 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

µðÁöÅÐ Çコ ½ÃÀå - ¸®Æ÷Æ®ÀÇ ¹üÀ§

¼¼°èÀÇ µðÁöÅÐ Çコ ½ÃÀå¿¡ °üÇÑ TMRÀÇ ¸®Æ÷Æ®´Â °ú°Å¿Í ÇöÀçÀÇ ¼ºÀå µ¿Çâ ¹× 2023-2031³âÀÇ ¿¹Ãø ±â°£ Áß ½ÃÀå ÁöÇ¥ÀÇ ±ÍÁßÇÑ ÀλçÀÌÆ®¸¦ ¾òÀ» ±âȸ¸¦ ¿¬±¸Çϰí ÀÖ½À´Ï´Ù. ÀÌ ¸®Æ÷Æ®´Â ¼¼°èÀÇ µðÁöÅÐ Çコ ½ÃÀåÀÇ ¸ÅÃâÀ» Á¦°øÇÕ´Ï´Ù. 2017-2031³â ±â°£, 2023³âÀ» ±âÁسâ, 2031³âÀ» ¿¹Ãø³âÀ¸·Î °£ÁÖÇÕ´Ï´Ù. ÀÌ ¸®Æ÷Æ®´Â 2023-2031³â ¼¼°èÀÇ µðÁöÅÐ Çコ ½ÃÀåÀÇ ¿¬°£ º¹ÇÕ ¼ºÀå·ü(CAGR %)µµ Á¦°øÇÕ´Ï´Ù.

ÀÌ ¸®Æ÷Æ®´Â ±¤¹üÀ§ÇÑ Á¶»ç¸¦ °ÅÃÄ ÀÛ¼ºµÇ¾ú½À´Ï´Ù. 1Â÷ Á¶»ç¿¡¼­´Â Á¶»ç Ȱµ¿ÀÇ ´ëºÎºÐÀÌ ½ÃÇàµÇ°í, ¾Ö³Î¸®½ºÆ®°¡ ÁÖ¿ä ¿ÀÇǴϾ𠸮´õ, ¾÷°è ¸®´õ, ¿ÀÇǴϾð Á¦Á¶¾÷ü¿Í ÀÎÅͺ並 ÁøÇàÇß½À´Ï´Ù. 2Â÷ Á¶»ç¿¡´Â µðÁöÅÐ Çコ ½ÃÀåÀ» ÀÌÇØÇϱâ À§ÇØ ÁÖ¿ä ±â¾÷ÀÇ Á¦Ç° ¹®Çå, ¿¬Â÷º¸°í¼­, ÇÁ·¹½º ¸±¸®½º ¹× °ü·Ã ¹®¼­ ÂüÁ¶°¡ Æ÷ÇԵ˴ϴÙ.

½ÃÀå ½º³À¼ô
2023³â ½ÃÀå °¡Ä¡ 3,825¾ï ´Þ·¯
2031³â ½ÃÀå °¡Ä¡ 1Á¶ 1,000¾ï ´Þ·¯
CAGR 13.1%

ÀÌ ¸®Æ÷Æ®´Â ¼¼°èÀÇ µðÁöÅÐ Çコ ½ÃÀåÀÇ °æÀï ±¸µµ¸¦ ÀÚ¼¼ÇÏ°Ô Á¶»çÇϰí ÀÖ½À´Ï´Ù. ¼¼°èÀÇ µðÁöÅÐ Çコ ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ÁÖ¿ä ±â¾÷ÀÌ ½Äº°µÇ°í, °¢°¢ÀÇ ±â¾÷ÀÌ ´Ù¾çÇÑ ¼Ó¼ºÀÇ Ãø¸é¿¡¼­ ÇÁ·ÎÆÄÀϸµµÇ°í ÀÖ½À´Ï´Ù. ȸ»ç °³¿ä, À繫 »óȲ, ÃÖ±Ù µ¿Çâ, SWOT´Â ÀÌ ¸®Æ÷Æ®¿¡¼­ ¼Ò°³µÇ°í ÀÖ´Â ¼¼°èÀÇ µðÁöÅÐ Çコ ½ÃÀå¿¡¼­ ±â¾÷ÀÇ ¼Ó¼ºÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÀüÁ¦Á¶°Ç°ú Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à : ¼¼°è ½ÃÀå

Á¦4Àå ½ÃÀå °³¿ä

  • ¼­·Ð
  • °³¿ä
  • ½ÃÀå ¿ªÇÐ
  • ¼¼°è ½ÃÀåÀÇ ºÐ¼®°ú ¿¹Ãø, 2017-2031³â

Á¦5Àå ÁÖ¿ä ÀλçÀÌÆ®

  • µ¿Çâ
    • Ŭ¶ó¿ìµå ±â¹Ý ½Ã½ºÅÛ µµÀÔÀÇ Áõ°¡
    • °¡»óÈ­ Å×Å©³î·¯Áö¿Í ±â¼úÀÇ Áøº¸¿¡ ÀÇÇØ ÇコÄɾî IT¿¡ »õ·Î¿î Â÷¿øÀÌ ´õÇØÁø´Ù.
  • µðÁöÅÐ Ä¡·á ºñÁî´Ï½º, ±âȸ, ½Å±Ô ½ÃÀå Âü¿©ÀÚÀÇ ÁøÀÔ À庮
  • ½ÃÀå¿¡¼­ ºñÁî´Ï½º ¸ðµ¨¿¡ °üÇÑ Á¤¼ºÀû Á¤º¸
  • ±âÁ¸ ºñÁî´Ï½º ¸ðµ¨ : ±âÁ¸ ºñÁî´Ï½º ¸ðµ¨¿¡ ´ëÇÑ °úÁ¦
  • »õ·Î¿î ºñÁî´Ï½º ¸ðµ¨
  • µµÀÔ : ÃÖÁ¾»ç¿ëÀÚº°
  • µðÁöÅÐ Ä¡·á ¼ö¿äÀÇ ¿µÇâ ¿äÀÎ
  • ¼¼°èÀÇ ÇコÄɾîºñ : ÁÖ¿ä ±¹°¡º°
  • µðÁöÅÐ ÀÇ·á ºñÁî´Ï½º ¸ðµ¨
  • µðÁöÅÐ Ä¡·á Á¦Ç°ÀÇ ÁÖ¸ñµµ¸¦ ³ôÀÌ´Â ¿äÀÎ
    • ÇコÄɾîºñ
    • °¡Ä¡ ±â¹Ý °áÁ¦ ¸ðµ¨
    • º¥Ã³ ÀÚ±ÝÁ¶´Þ
    • ±âŸ

Á¦6Àå ¼¼°è ½ÃÀåÀÇ ºÐ¼®°ú ¿¹Ãø : Á¦Ç°º°

  • ¼­·Ð°ú Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú/¹ßÀü
  • ½ÃÀå ±Ý¾× ¿¹Ãø : Á¦Ç°º°, 2017-2031
    • ÇコÄɾî Á¤º¸ ½Ã½ºÅÛ
      • ÀÓ»ó ¼Ö·ç¼Ç
        • EHR/EMR
        • ÀÓ»óÀÇ»ç°áÁ¤Áö¿ø½Ã½ºÅÛ(CDSS)
        • CPOE(Computerized Physician Order Entry)
        • ¸ð¹ÙÀÏ Çコ
        • Ä¿³ØÆ¼µå ÀÇ·á±â±â
        • ¸ð¹ÙÀÏ Çコ ÄÄÆ÷³ÍÆ®
        • ÇÇÆ®´Ï½º ¾Û
        • ÀÇ·á ÂüÁ¶
        • ÇÇÆ®´Ï½º ¾Û
        • À£´Ï½º
        • º´»ó °ü¸®
        • ¿µ¾ç
        • ¿ø°Ý »ó´ã
        • ¸®¸¶Àδõ¿Í ¾ó·¯Æ®
        • ±âŸ
        • ¿ø°ÝÀÇ·á
        • Áý´Ü°Ç°­°ü¸®
        • ±âŸ
      • ºñÀÓ»ó ¼Ö·ç¼Ç
    • ¿þ¾î·¯ºí µð¹ÙÀ̽º
      • Áø´Ü ¹× °¨½Ã µð¹ÙÀ̽º
      • µðÁöÅÐ Ä¡·á ±â±â
        • ÅëÁõ °ü¸® ±â±â
        • ÀçȰ ±â±â
        • È£Èí ¿ä¹ý ±â±â
        • Àν¶¸° ÆßÇÁ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Á¦Ç°º°

Á¦7Àå ¼¼°è ½ÃÀåÀÇ ºÐ¼®°ú ¿¹Ãø : ÄÄÆ÷³ÍÆ®º°

  • ¼­·Ð°ú Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú/¹ßÀü
  • ½ÃÀå ±Ý¾× ¿¹Ãø : ÄÄÆ÷³ÍÆ®º°, 2017-2031
    • ¼ÒÇÁÆ®¿þ¾î
    • Çϵå¿þ¾î
    • ¼­ºñ½º
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÄÄÆ÷³ÍÆ®º°

Á¦8Àå ¼¼°è ½ÃÀåÀÇ ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼­·Ð°ú Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú/¹ßÀü
  • ½ÃÀå ±Ý¾× ¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°, 2017-2031
    • B2C
      • ȯÀÚ
      • °£º´ÀÎ
    • B2B
      • ÇÁ·Î¹ÙÀÌ´õ
      • ÁöºÒÀÚ
      • °í¿ëÁÖ
      • Á¦¾àȸ»ç
      • ±âŸ
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ¼¼°è ½ÃÀåÀÇ ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ±Ý¾× ¿¹Ãø : Áö¿ªº°, 2017-2031
    • ºÏ¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼® : Áö¿ªº°

Á¦10Àå ºÏ¹Ì ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦11Àå À¯·´ ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦13Àå ¶óÆ¾¾Æ¸Þ¸®Ä« ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦14Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå ±â¾÷ - °æÀï ¸ÅÆ®¸¯½º(±â¾÷ÀÇ °èÃþ ¹× ±Ô¸ðº°)
  • ½ÃÀå Á¡À¯À² ºÐ¼® : ±â¾÷º°, 2022³â
  • ±â¾÷ °³¿ä
    • Agfa-Gevaert NV
    • Cerner Corporation
    • Allscripts Healthcare Solutions, Inc.
    • McKesson Corporation
    • Philips Healthcare
    • GE Healthcare
    • Siemens Healthineers
    • Epic Systems Corporation.
    • Merative
    • Alphabet Inc.
    • Qualcomm, Inc.
    • UnitedHealth Group(Optum)
    • Cisco Systems, Inc.
KSA 23.10.25

Digital Health Market - Scope of Report

TMR's report on the global digital health market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global digital health market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global digital health market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the digital health market.

Market Snapshot
Market Value in 2023US$ 382.5 Bn
Market Value in 2031US$ 1.1 Trn
CAGR13.1%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global digital health market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global digital health market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global digital health market.

The report delves into the competitive landscape of the global digital health market. Key players operating in the global digital health market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global digital health market profiled in this report.

Key Questions Answered in Global Digital Health Market Report:

  • What is the sales/revenue generated by digital health across all regions during the forecast period?
  • What are the opportunities in the global digital health market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Digital Health Market - Research Objectives and Research Approach

The comprehensive report on the global digital health market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global digital health market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global digital health market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Digital Health Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Digital Health Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Trends
    • 5.1.1. Increase in Adoption of Cloud-based Systems
    • 5.1.2. Virtualization Technologies and Technological Advancements Add New Dimensions to Healthcare IT
  • 5.2. Digital Therapeutic Business, Opportunities, and Entry Barriers for New Market Entrants
  • 5.3. Qualitative Information on Business Models in Digital Health Market
  • 5.4. Traditional Business Model: Challenges to Traditional Business Model
  • 5.5. New Digital Health Business Model
  • 5.6. Adoption of Digital Healthcare, by End-users
  • 5.7. Impact Factor for Digital Therapeutic Demand
  • 5.8. Global Healthcare Expenditure, by Major Countries
  • 5.9. Digital Medicine Business Model
  • 5.10. Factors Increasing Traction of Digital Therapeutic Products
    • 5.10.1. Healthcare Costs
    • 5.10.2. Value-based Payment Models
    • 5.10.3. Venture Funding
    • 5.10.4. Others

6. Global Digital Health Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product, 2017-2031
    • 6.3.1. Healthcare Information Systems
      • 6.3.1.1. Clinical Solutions
        • 6.3.1.1.1. EHR/EMR
        • 6.3.1.1.2. Clinical Decision Support System (CDSS)
        • 6.3.1.1.3. Computerized Physician Order Entry (CPOE)
        • 6.3.1.1.4. mHealth
        • 6.3.1.1.4.1. Connected Medical Devices
        • 6.3.1.1.4.2. mHealth Components
        • 6.3.1.1.4.2.1. Fitness App
        • 6.3.1.1.4.2.2. Medical Reference
        • 6.3.1.1.4.2.3. Fitness App
        • 6.3.1.1.4.2.4. Wellness
        • 6.3.1.1.4.2.5. Medical Condition Management
        • 6.3.1.1.4.2.6. Nutrition
        • 6.3.1.1.4.2.7. Remote Consultation
        • 6.3.1.1.4.2.8. Reminders and Alerts
        • 6.3.1.1.4.2.9. Others
        • 6.3.1.1.5. Telehealth
        • 6.3.1.1.6. Population Health Management
        • 6.3.1.1.7. Others
      • 6.3.1.2. Non-clinical Solutions
    • 6.3.2. Wearable Devices
      • 6.3.2.1. Diagnostic and Monitoring Devices
      • 6.3.2.2. Digital Therapeutic Devices
        • 6.3.2.2.1. Pain Management Devices
        • 6.3.2.2.2. Rehabilitation Devices
        • 6.3.2.2.3. Respiratory Therapy Devices
        • 6.3.2.2.4. Insulin Pumps
  • 6.4. Market Attractiveness Analysis, by Product

7. Global Digital Health Market Analysis and Forecast, by Component

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Component, 2017-2031
    • 7.3.1. Software
    • 7.3.2. Hardware
    • 7.3.3. Services
  • 7.4. Market Attractiveness Analysis, by Component

8. Global Digital Health Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. B2C
      • 8.3.1.1. Patients
      • 8.3.1.2. Caregivers
    • 8.3.2. B2B
      • 8.3.2.1. Providers
      • 8.3.2.2. Payers
      • 8.3.2.3. Employers
      • 8.3.2.4. Pharmaceutical Companies
      • 8.3.2.5. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Digital Health Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Digital Health Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Product, 2017-2031
    • 10.2.1. Healthcare Information Systems
      • 10.2.1.1. Clinical Solutions
        • 10.2.1.1.1. EHR/EMR
        • 10.2.1.1.2. Clinical Decision Support System (CDSS)
        • 10.2.1.1.3. Computerized Physician Order Entry (CPOE)
        • 10.2.1.1.4. mHealth
        • 10.2.1.1.4.1. Connected Medical Devices
        • 10.2.1.1.4.2. mHealth Components
        • 10.2.1.1.4.2.1. Fitness App
        • 10.2.1.1.4.2.2. Medical Reference
        • 10.2.1.1.4.2.3. Fitness App
        • 10.2.1.1.4.2.4. Wellness
        • 10.2.1.1.4.2.5. Medical Condition Management
        • 10.2.1.1.4.2.6. Nutrition
        • 10.2.1.1.4.2.7. Remote Consultation
        • 10.2.1.1.4.2.8. Reminders and Alerts
        • 10.2.1.1.4.2.9. Others
        • 10.2.1.1.5. Telehealth
        • 10.2.1.1.6. Population Health Management
        • 10.2.1.1.7. Others
      • 10.2.1.2. Non-clinical Solutions
    • 10.2.2. Wearable Devices
      • 10.2.2.1. Diagnostic and Monitoring Devices
      • 10.2.2.2. Digital Therapeutic Devices
        • 10.2.2.2.1. Pain Management Devices
        • 10.2.2.2.2. Rehabilitation Devices
        • 10.2.2.2.3. Respiratory Therapy Devices
        • 10.2.2.2.4. Insulin Pumps
  • 10.3. Market Value Forecast, by Component, 2017-2031
    • 10.3.1. Software
    • 10.3.2. Hardware
    • 10.3.3. Services
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. B2C
      • 10.4.1.1. Patients
      • 10.4.1.2. Caregivers
    • 10.4.2. B2B
      • 10.4.2.1. Providers
      • 10.4.2.2. Payers
      • 10.4.2.3. Employers
      • 10.4.2.4. Pharmaceutical Companies
      • 10.4.2.5. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Component
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Digital Health Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product, 2017-2031
    • 11.2.1. Healthcare Information Systems
      • 11.2.1.1. Clinical Solutions
        • 11.2.1.1.1. EHR/EMR
        • 11.2.1.1.2. Clinical Decision Support System (CDSS)
        • 11.2.1.1.3. Computerized Physician Order Entry (CPOE)
        • 11.2.1.1.4. mHealth
        • 11.2.1.1.4.1. Connected Medical Devices
        • 11.2.1.1.4.2. mHealth Components
        • 11.2.1.1.4.2.1. Fitness App
        • 11.2.1.1.4.2.2. Medical Reference
        • 11.2.1.1.4.2.3. Fitness App
        • 11.2.1.1.4.2.4. Wellness
        • 11.2.1.1.4.2.5. Medical Condition Management
        • 11.2.1.1.4.2.6. Nutrition
        • 11.2.1.1.4.2.7. Remote Consultation
        • 11.2.1.1.4.2.8. Reminders and Alerts
        • 11.2.1.1.4.2.9. Others
        • 11.2.1.1.5. Telehealth
        • 11.2.1.1.6. Population Health Management
        • 11.2.1.1.7. Others
      • 11.2.1.2. Non-clinical Solutions
    • 11.2.2. Wearable Devices
      • 11.2.2.1. Diagnostic and Monitoring Devices
      • 11.2.2.2. Digital Therapeutic Devices
        • 11.2.2.2.1. Pain Management Devices
        • 11.2.2.2.2. Rehabilitation Devices
        • 11.2.2.2.3. Respiratory Therapy Devices
        • 11.2.2.2.4. Insulin Pumps
  • 11.3. Market Value Forecast, by Component, 2017-2031
    • 11.3.1. Software
    • 11.3.2. Hardware
    • 11.3.3. Services
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. B2C
      • 11.4.1.1. Patients
      • 11.4.1.2. Caregivers
    • 11.4.2. B2B
      • 11.4.2.1. Providers
      • 11.4.2.2. Payers
      • 11.4.2.3. Employers
      • 11.4.2.4. Pharmaceutical Companies
      • 11.4.2.5. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product
    • 11.6.2. By Component
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Digital Health Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product, 2017-2031
    • 12.2.1. Healthcare Information Systems
      • 12.2.1.1. Clinical Solutions
        • 12.2.1.1.1. EHR/EMR
        • 12.2.1.1.2. Clinical Decision Support System (CDSS)
        • 12.2.1.1.3. Computerized Physician Order Entry (CPOE)
        • 12.2.1.1.4. mHealth
        • 12.2.1.1.4.1. Connected Medical Devices
        • 12.2.1.1.4.2. mHealth Components
        • 12.2.1.1.4.2.1. Fitness App
        • 12.2.1.1.4.2.2. Medical Reference
        • 12.2.1.1.4.2.3. Fitness App
        • 12.2.1.1.4.2.4. Wellness
        • 12.2.1.1.4.2.5. Medical Condition Management
        • 12.2.1.1.4.2.6. Nutrition
        • 12.2.1.1.4.2.7. Remote Consultation
        • 12.2.1.1.4.2.8. Reminders and Alerts
        • 12.2.1.1.4.2.9. Others
        • 12.2.1.1.5. Telehealth
        • 12.2.1.1.6. Population Health Management
        • 12.2.1.1.7. Others
      • 12.2.1.2. Non-clinical Solutions
    • 12.2.2. Wearable Devices
      • 12.2.2.1. Diagnostic and Monitoring Devices
      • 12.2.2.2. Digital Therapeutic Devices
        • 12.2.2.2.1. Pain Management Devices
        • 12.2.2.2.2. Rehabilitation Devices
        • 12.2.2.2.3. Respiratory Therapy Devices
        • 12.2.2.2.4. Insulin Pumps
  • 12.3. Market Value Forecast, by Component, 2017-2031
    • 12.3.1. Software
    • 12.3.2. Hardware
    • 12.3.3. Services
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. B2C
      • 12.4.1.1. Patients
      • 12.4.1.2. Caregivers
    • 12.4.2. B2B
      • 12.4.2.1. Providers
      • 12.4.2.2. Payers
      • 12.4.2.3. Employers
      • 12.4.2.4. Pharmaceutical Companies
      • 12.4.2.5. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product
    • 12.6.2. By Component
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Digital Health Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product, 2017-2031
    • 13.2.1. Healthcare Information Systems
      • 13.2.1.1. Clinical Solutions
        • 13.2.1.1.1. EHR/EMR
        • 13.2.1.1.2. Clinical Decision Support System (CDSS)
        • 13.2.1.1.3. Computerized Physician Order Entry (CPOE)
        • 13.2.1.1.4. mHealth
        • 13.2.1.1.4.1. Connected Medical Devices
        • 13.2.1.1.4.2. mHealth Components
        • 13.2.1.1.4.2.1. Fitness App
        • 13.2.1.1.4.2.2. Medical Reference
        • 13.2.1.1.4.2.3. Fitness App
        • 13.2.1.1.4.2.4. Wellness
        • 13.2.1.1.4.2.5. Medical Condition Management
        • 13.2.1.1.4.2.6. Nutrition
        • 13.2.1.1.4.2.7. Remote Consultation
        • 13.2.1.1.4.2.8. Reminders and Alerts
        • 13.2.1.1.4.2.9. Others
        • 13.2.1.1.5. Telehealth
        • 13.2.1.1.6. Population Health Management
        • 13.2.1.1.7. Others
      • 13.2.1.2. Non-clinical Solutions
    • 13.2.2. Wearable Devices
      • 13.2.2.1. Diagnostic and Monitoring Devices
      • 13.2.2.2. Digital Therapeutic Devices
        • 13.2.2.2.1. Pain Management Devices
        • 13.2.2.2.2. Rehabilitation Devices
        • 13.2.2.2.3. Respiratory Therapy Devices
        • 13.2.2.2.4. Insulin Pumps
  • 13.3. Market Value Forecast, by Component, 2017-2031
    • 13.3.1. Software
    • 13.3.2. Hardware
    • 13.3.3. Services
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. B2C
      • 13.4.1.1. Patients
      • 13.4.1.2. Caregivers
    • 13.4.2. B2B
      • 13.4.2.1. Providers
      • 13.4.2.2. Payers
      • 13.4.2.3. Employers
      • 13.4.2.4. Pharmaceutical Companies
      • 13.4.2.5. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product
    • 13.6.2. By Component
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Digital Health Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product, 2017-2031
    • 14.2.1. Healthcare Information Systems
      • 14.2.1.1. Clinical Solutions
        • 14.2.1.1.1. EHR/EMR
        • 14.2.1.1.2. Clinical Decision Support System (CDSS)
        • 14.2.1.1.3. Computerized Physician Order Entry (CPOE)
        • 14.2.1.1.4. mHealth
        • 14.2.1.1.4.1. Connected Medical Devices
        • 14.2.1.1.4.2. mHealth Components
        • 14.2.1.1.4.2.1. Fitness App
        • 14.2.1.1.4.2.2. Medical Reference
        • 14.2.1.1.4.2.3. Fitness App
        • 14.2.1.1.4.2.4. Wellness
        • 14.2.1.1.4.2.5. Medical Condition Management
        • 14.2.1.1.4.2.6. Nutrition
        • 14.2.1.1.4.2.7. Remote Consultation
        • 14.2.1.1.4.2.8. Reminders and Alerts
        • 14.2.1.1.4.2.9. Others
        • 14.2.1.1.5. Telehealth
        • 14.2.1.1.6. Population Health Management
        • 14.2.1.1.7. Others
      • 14.2.1.2. Non-clinical Solutions
    • 14.2.2. Wearable Devices
      • 14.2.2.1. Diagnostic and Monitoring Devices
      • 14.2.2.2. Digital Therapeutic Devices
        • 14.2.2.2.1. Pain Management Devices
        • 14.2.2.2.2. Rehabilitation Devices
        • 14.2.2.2.3. Respiratory Therapy Devices
        • 14.2.2.2.4. Insulin Pumps
  • 14.3. Market Value Forecast, by Component, 2017-2031
    • 14.3.1. Software
    • 14.3.2. Hardware
    • 14.3.3. Services
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. B2C
      • 14.4.1.1. Patients
      • 14.4.1.2. Caregivers
    • 14.4.2. B2B
      • 14.4.2.1. Providers
      • 14.4.2.2. Payers
      • 14.4.2.3. Employers
      • 14.4.2.4. Pharmaceutical Companies
      • 14.4.2.5. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Component
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company, 2022
  • 15.3. Company Profiles
    • 15.3.1. Agfa-Gevaert N.V.
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Cerner Corporation
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Allscripts Healthcare Solutions, Inc.
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. McKesson Corporation
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Philips Healthcare
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. GE Healthcare
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Siemens Healthineers
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Epic Systems Corporation.
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Merative
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Alphabet Inc.
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview
    • 15.3.11. Qualcomm, Inc.
      • 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.11.2. Product Portfolio
      • 15.3.11.3. Financial Overview
      • 15.3.11.4. SWOT Analysis
      • 15.3.11.5. Strategic Overview
    • 15.3.12. UnitedHealth Group (Optum)
      • 15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.12.2. Product Portfolio
      • 15.3.12.3. Financial Overview
      • 15.3.12.4. SWOT Analysis
      • 15.3.12.5. Strategic Overview
    • 15.3.13. Cisco Systems, Inc.
      • 15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.13.2. Product Portfolio
      • 15.3.13.3. Financial Overview
      • 15.3.13.4. SWOT Analysis
      • 15.3.13.5. Strategic Overview
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦